News
The results found that Lee Silverman Voice Treatment (LSVT LOUD) is more effective than NHS speech and language therapy.
We're providing £1.24m through our Virtual Biotech programme to help test a potential treatment called MTX325 in people with Parkinson’s.
We're providing £1.55m through our Virtual Biotech programme to carry out the first clinical trials to see if HER-096 is safe for people with Parkinson’s and to start exploring its potential benefits.
Parkinson's UK is funding researchers to develop a potential set of drugs against a new target for people with Parkinson's.
‘I Hear You’, a soundscape of the unheard world of young onset Parkinson’s supported by Parkinson’s UK, was premiered at Bloomsbury Studio, London on Tuesday 11 June.
Research co-funded by Parkinson’s UK finds a new way to potentially improve diagnosis and monitoring of Parkinson’s.
We’ve supported the principle that everyone in Scotland who needs it should have a legal right to palliative care. However, the new law would need additional funding and to be on the right terms for people with Parkinson’s and their families.
We're providing £1.6m through our Virtual Biotech programme to develop a potential new treatment targeting mitochondria to protect brain cells in Parkinson's patients.
A partnership involving Parkinson’s UK has been recognised at the Made with Patients awards, organised by Patient Focused Medicines Development.
We briefed MPs ahead of a parliamentary debate on mental health support for people living with long-term health conditions.